Affimed Presents Preclinical Data Showing that Addition of an Innate Cell Engager to NK and CAR-NK Cells Improves Tumor Cytotoxicity of Both Cell Types at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
November 3, 2023
November 3, 2023
November 2, 2023
November 1, 2023
October 4, 2023
September 27, 2023
September 21, 2023
September 12, 2023
September 7, 2023
August 22, 2023
August 10, 2023